| Date | Time | Source | Headline | Symbol | Company |
| 01/09/2024 | 6:12AM | IH Market News | Wall Street Highlights: HPE and Juniper Networks in Negotiations, Elliott Invests $1 Billion in Match Group, and More | NASDAQ:SGEN | Seagen Inc |
| 12/26/2023 | 6:12AM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:SGEN | Seagen Inc |
| 12/18/2023 | 6:46PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/18/2023 | 5:25PM | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:55PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:46PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:42PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:39PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:38PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:32PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:29PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:24PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:16PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:16PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:10PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:10PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 6:05PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SGEN | Seagen Inc |
| 12/15/2023 | 5:00PM | PR Newswire (US) | PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:47AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:46AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:45AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:44AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:43AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:42AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:41AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:40AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:39AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:38AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |
| 12/14/2023 | 8:37AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:SGEN | Seagen Inc |